Publications by authors named "Howard McLeod"

Claim this Profile
P
Propranolol metabolite and enantiomers affect colorectal cancer development by inhibiting MAPK pathway and downregulating PD-1 expression.
Hanying Yi, Yingying Dai, Cuiyu Chen, Wenjuan Ma, Yu Zhang, Howard L Mcleod

Int Immunopharmacol· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A two-stage genome-wide association study to identify novel genetic loci associated with irAEs in lung cancer patients receiving PD-1/PD-L1 inhibitors.
Lei She, Juan Chen, Jun-Yan Liu, Jia-Si Liu, Xiao-Ping Tang, Howard L McLeod

Cancer Lett· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the science of genomic learning healthcare systems.
Teri A Manolio, Renee Rider, Carol J Bult, Rex L Chisholm, Patricia A Deverka, Howard L McLeod

Learn Health Syst· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of oncology biomarker testing in managed care: Best practices and consensus recommendations from an AMCP Market Insights program.
Diana Brixner, Terry Richardson, Catherine M Lockhart, Scott Ramsey, John Fox, Howard Mcleod

J Manag Care Spec Pharm· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function.
Yu Zhang, Feng Yu, Jing Ouyang, Panpan Liu, Yingying Dai, Howard McLeod

J Immunother Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal effects of immune cells on the efficacy and adverse drug reactions of platinum drugs.
Wanting Li, Bing Yu, Qi Xiao, Zhao Zhang, Hanxue Huang, Howard L McLeod

Acta Biochim Biophys Sin (Shanghai)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in Oncology-Running Out of Excuses for Slow Adoption.
Howard L McLeod, D Grace Nguyen

JAMA Netw Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.
Kevin C Flanagan, Jon Earls, Jeffrey Hiken, Rachel L Wellinghoff, Michelle M Ponder, Howard L McLeod

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
Daniel L Hertz, Chad A Bousman, Howard L McLeod, Andrew A Monte, Deepak Voora

Am J Health Syst Pharm· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deceptive learning in histopathology.
Sahar Shahamatdar, Daryoush Saeed-Vafa, Drew Linsley, Farah Khalil, Katherine Lovinger, Howard T McLeod

Histopathology· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.
Yang Wang, Yu Zhang, Jing Ouyang, Hanying Yi, Shiyu Wang, Howard L Mcleod

Cell Oncol (Dordr)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Howard L McLeod

BMC Genomics· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
Sharon P Shriver, Devon Adams, Brittany Avin McKelvey, Jeannine S McCune, Dale Miles, Howard L McLeod

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, Valérie Boige, Robert B Diasio, Howard L McLeod

Br J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).
Jai N Patel, Chen Jiang, Kouros Owzar, Daniel L Hertz, Janey Wang, Howard L McLeod

Pharmacogenomics J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HerediGene Population Study IT infrastructure: A model to support genomic research recruitment and precision public health.
David P Taylor, Bret S E Heale, Benjamin Chisum, G Bryce Christensen, Darin F Wilcox, Howard L McLeod

AMIA Annu Symp Proc· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial.
Scott A Mosley, Emily Cicali, Alex Del Cueto, Diane G Portman, Kristine A Donovan, Howard L McLeod

Pharmacotherapy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-2 levels in metastatic colorectal cancer patients (Alliance).
Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Howard L McLeod

medRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L Wellinghoff, Howard Mcleod

J Cancer Res Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic Analyses Implicate B Cell Developmental Status and as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy.
George W Small, Farida S Akhtari, Adrian J Green, Tammy M Havener, Michael Sikes, Howard L McLeod

Cells· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Testing: Time to Put Patient Safety First.
Sharyn D Baker, Susan E Bates, Gabriel A Brooks, William L Dahut, Robert B Diasio, Howard L McLeod

J Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for Response to Anti-PD-1/Anti-PD-L1 Immune Checkpoint Inhibitors: A Large Meta-Analysis.
Arshiya Mariam, Suneel Kamath, Kimberly Schveder, Howard L McLeod, Daniel M Rotroff

Oncology (Williston Park)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients.
Ricardo D Gonzalez, George W Small, Adrian J Green, Farida S Akhtari, Tammy M Havener, Howard L McLeod

Pharmaceuticals (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients.
Ricardo D Gonzalez, George W Small, Adrian J Green, Farida S Akhtari, Alison A Motsinger-Reif, Howard L McLeod

Pharmaceuticals (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of an Infrastructure to Facilitate the Use of Whole Genome Sequencing for Population Health.
Nephi A Walton, Brent Hafen, Sara Graceffo, Nykole Sutherland, Melanie Emmerson, Howard L McLeod

J Pers Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis